Sequenom Inc. (SQNM) Reports Financial Results For The Fourth Quarter And Full Year Of 2013
2/28/2014 6:25:00 AM
SAN DIEGO, Feb. 27, 2014 -- /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today reported total revenues of $45.1 million for the fourth quarter and $162.4 million for the full year of 2013. Net loss was $18.9 million, or $0.16 per share, for the fourth quarter and $107.4 million, or $0.93 per share, for the full year.
Help employers find you! Check out all the jobs and post your resume.
comments powered by